liveonearth (liveonearth) wrote,

New Tx for Metastatic Melanoma: PLX4032

melanoma prognosis: good if caught before mets, poor after (9 mo survival)
9,000 pts/yr die of it in US
drugs currently approved to tx metastatic melanoma: interleukin-2 and dacarbazine
benefit less than 20% of pts

experimental anticancer drug: PLX4032
developed by Plexxikon Inc. of Berkeley
licensed to Roche Pharmaceuticals
may help with other cancers that share this mutation

PLX4032 targets BRAF gene that stims tumor growth
about 50% of melanoma pts have mutated gene that won't shut off, BRAF protein produced constantly
drug benefits 80%+ of patients with metastatic melanoma, tho only for about 8 mo no tumor progression
tumors become resistant to the drug

small Phase II clinical trial (n=32 with BRAF mutation)-->larger Phase III trial next
reported in NEJM
drug given oral bid, less SEs than chemo
in 26 pts tumor shrank 30%+, 2 other pts had lesser tumor size reductions, 2 pts had tumors disappear

to enroll in trials at UCLA call (888) 798-0719.

Tags: cancer, medicine, melanoma, pharmacology, skin

  • QotD: I Think

    I think, therefore I am... confused. --Benjamin Hoff in The Tao of Pooh

  • QotD: Twain again

    Few things are harder to put up with than the annoyance of a good example. --Mark Twain

  • QotD: Gatofeo

    An ugly cat. Vast desert. Smoke and fire. Flying lead makes holes in parchment. The ugly cat is much amused. --- Gatodamus (1503-1566)…

  • Post a new comment


    Comments allowed for friends only

    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded